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Abstract
Background: Psychiatric patients are more likely to be victims of crime than others in the community. Dual
diagnosis patients with comorbid psychiatric and substance use disorders are especially prone to victimization.
Victimization is associated with substance abuse, more severe symptomatology and homelessness. There is a strong
need for interventions to reduce victimization in this population. We developed the Self-wise, Other-wise,
Streetwise (SOS) training to reduce victimization in patients with dual diagnosis.
Methods/design: This study is a randomized controlled trial using a parallel group design to determine the
effectiveness of adding the SOS training to care as usual. Patients with dual diagnosis (N = 250) will be allocated to
either care as usual plus SOS training (N = 125) or care as usual only (N = 125) using computer-generated stratified
block randomization. To compare effectiveness participants will be interviewed at baseline and 2, 8 and 14 months
follow-up. The primary outcome measure is treatment response (yes/no), defined as either no victimization at
14 months follow-up or at least a 50 % reduction in incidents of victimization at 14 months follow-up compared to
baseline assessment. Victimization is measured with the Safety Monitor, an adequate self-report instrument used by
Statistics Netherlands to measure victimization on a large scale in the Netherlands. Outcome assessors are blind to
treatment allocation. An economic evaluation will be performed alongside the randomized controlled trial and will
take the societal perspective.
Discussion: This study is the first randomized controlled trial to examine the effectiveness of an intervention that
aims to reduce victimization in patients with dual diagnosis. If the intervention is effective it can be implemented in
mental health care and contribute to the safety and well-being of patients.
Trial registration: Dutch Trial Register (NTR): 4472, date of registration: 24-03-2014.
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Background
In contrast to what the general public assumes, psychi-
atric patients are more often victims of crime than per-
petrators [1–3]. A systematic review on the prevalence
of violent victimization of patients with severe mental
illness (SMI) indicates that these patients are more likely
to be violently victimized than other community mem-
bers [2]. In addition to violent victimization, psychiatric
patients are more often a victim of property crime [3].
Recent research in the Netherlands showed an annual
prevalence rate of victimization in SMI outpatients of
47 % compared to 32 % in the general population [4].
Dual diagnosis patients with comorbid psychiatric and sub-
stance use disorders are especially prone to victimization
[2, 5, 6]. These patients are approximately 1.3–5.4 times
more likely to be violently victimized than psychiatric pa-
tients without substance use disorders [2, 5].
Victimization is associated with physical injury, psy-
chological distress and impaired occupational function-
ing [7–9], but also with posttraumatic stress disorder,
major depression, substance abuse and difficulties with
emotion regulation and assertiveness [7, 9–13]. In SMI
patients, victimization is associated with more severe
symptomatology and poorer illness course [14–16],
more substance abuse [14, 15, 17, 18], depression [18],
homelessness [15, 17], violent behavior [19], offending
[20] and interpersonal problems [21]. In substance-
dependent patients, victimization is associated with psy-
chological distress [22], worse psychiatric status, more
psychiatric hospitalizations and outpatient treatment,
worse general level of functioning [23], worse addiction
illness-course [24] and offending [25].
Since most studies used cross-sectional designs, the exact
mechanisms behind these associations remain unclear. It is
however plausible that these problems associated with
victimization, such as substance abuse, more severe symp-
tomatology and homelessness, are consequences as well as
predictors of victimization [12, 14, 24, 26–28]; This may
cause a destructive vicious cycle of victimization, substance
use and severe symptomatology. In line with this is the
finding that an accurate predictor of victimization is having
a history of victimization [26, 29–32]. One explanation of
this victimization-revictimization link is that some are
more prone to become a victim than others, due to
personal characteristics, lifestyle and living environ-
ment [33, 34]. There is however evidence that revicti-
mization is partly the result of changes following
victimization, like emotion dysregulation, more sub-
stance use, offending, depression and posttraumatic
stress disorder [12, 24, 32, 35].
Victimization of patients is an important concern not
only because of its huge effect on mental and physical
health, but also because of the significant societal and
economic consequences of violence, due to increased
burden on social services, healthcare and justice systems
and productivity losses [36]. Reducing victimization in
psychiatric patients may have long-lasting effects on per-
sonal well-being, the number of criminal offenses in so-
ciety and economic costs. Consequently, there is a
strong need for interventions to reduce victimization in
psychiatric patients [2–4, 37–39]. Patients with dual
diagnosis are the most vulnerable to victimization [2, 3, 5].
There is a lack of evidence-based treatment options
for patients with substance use disorders co-occurring
with severe mental illness [40] or posttraumatic stress
disorder [41]. Therefore, we developed an interven-
tion, the Self-wise, Other-wise, Streetwise (SOS) train-
ing, that aims to reduce vulnerability to victimization
in patients with dual diagnosis.
SOS training focusses on the modifiable risk factors
for victimization, which are subdivided into three differ-
ent themes, represented in three training modules. The
module Self-wise targets emotion regulation skills, the
module Other-wise targets assertiveness and conflict
resolution skills and the module Streetwise targets know-
ledge and skills to enhance personal safety and reduce
vulnerability. As no evidence-based interventions are
available so far, SOS training is based on evidence based
treatment programs in other patient groups that target
these skills [42–46]. SOS training is adapted to the needs
of patients with substance use disorders co-occurring
with any other mental disorders and can therefore be
widely used in clinical practice.
By adding SOS training to care as usual (CAU) we
expect patients to improve on psychopathology, emo-
tion regulation skills, interpersonal problems and self-
esteem. Besides, adding SOS training to CAU is
expected to result in a decrease in substance use. We
expect that these improvements will result in a reduc-
tion of victimization.
Aims of the trial
This study aims to investigate the effectiveness of SOS
training in reducing victimization of patients with dual
diagnosis.
The primary research question is:
1. Does adding SOS training to CAU result in a
larger reduction of victimization compared to
CAU alone?
Secondary research questions are:
2. Does adding SOS training to CAU result in a larger
improvement on secondary outcome measures
compared to CAU alone?
3. How do costs and effects of SOS training + CAU
compare to CAU from a societal perspective?
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Methods/design
Design
This study is a single-blind two-arm randomized con-
trolled trial using a parallel group design to determine
the effectiveness of adding SOS training to CAU. Partici-
pants will be interviewed at baseline and 2, 8 and
14 months follow-up. After baseline assessment, partici-
pants will be randomly allocated to either CAU + SOS
training or CAU.
Participants
Participants will be recruited in an addiction-psychiatry
clinic and an addiction-psychiatry outpatient care facility
in Amsterdam. Inclusion criteria are (1) 18 years of age
or older; (2) substance dependence or substance abuse
(involving alcohol and/or illegal drugs, including canna-
bis) according to Diagnostic and Statistical Manual of
Mental Disorders-IV (DSM-IV) criteria; and (3) at least
one other mental disorder on DSM-IV Axis I or II. Pa-
tients are excluded from the study if they (1) do not have
sufficient understanding of the Dutch language; or (2)
are not eligible for group therapy according to their case
manager, due to for instance severe anti-social or psy-
chopathic traits; (3) are not willing to provide informed
consent. Based on a priori power analysis, we aim to in-
clude 250 (2x125) participants in this study.
Interventions
Self-wise, Other-wise, Streetwise (SOS) training
The experimental add-on intervention, SOS training, is a
12 session group-based training [47]. Sessions take place
twice a week and take 75 min. Each session utilizes learn-
ing techniques such as role playing, visual material, group
discussions and sharing experiences. The trainers create a
safe and respectful environment. Participants can give
each other tokens of appreciation during every session, in
order to reinforce desirable behaviour. These tokens are
cards with coloured stars. By using the tokens, partici-
pants learn to reinforce and support each other. Further-
more, the tokens stimulate the participants to listen to
and interact with each other. The training comprises 3
modules, Self-wise, Other-wise and Streetwise. Each mod-
ule consists of 4 sessions. There is no specific order in
which participants follow these modules.
The module Self-wise involves a transdiagnostic emo-
tion regulation skills training. Emotion regulation refers
to the ability to monitor, evaluate and modify emotional
reactions to accomplish one’s goals [48]. Emotion dys-
regulation is a predictor of victimization [12, 49–51].
Lack of emotional awareness, for instance the inability
to recognize and interpret fear cues, impairs risk percep-
tion [12, 52]. Poor risk perception increases the risk for
victimization [49, 52]. Emotion dysregulation, especially
impulsivity, also increases the likelihood of entering a
risky situation and makes it more difficult to leave or ad-
equately cope with a dangerous situation [12, 52]. Even
small increases in emotion regulation can impact
victimization risk substantially [12]. Since no evidence-
based emotion regulation skills training is available for
our target group, the content of Self-wise is inspired by
elements of affect regulation therapy for major depres-
sive disorder [42], anger management training for people
with intellectual disabilities [43], skills training in affect
and interpersonal regulation for patients with posttrau-
matic stress disorder related to childhood abuse [44] and
the system training for emotional predictability and
problem solving for patients with borderline personality
disorder [45]. Self-wise is a new, simplified emotion
regulation skills training suitable for patients with dual
diagnosis, based on the principles of these interventions.
The module Other-wise involves a conflict resolution
skills training. Offending, violent behaviour, interpersonal
problems and lack of assertiveness increase the risk for
victimization [13, 19–21, 25]. Aggressive responses to
provocation can easily lead to an escalation of violence. On
the other hand, non-assertive responses can provoke ma-
nipulation and exploitation. The content of Other-wise is
inspired by social skills training for patients with schizo-
phrenia [46]. In this module patients compose a list of im-
portant skills for preventing and resolving conflicts, which
are practiced in role-playing exercises categorized by theme.
Examples of these themes are: Responding to Frustrating
Situations, Handling Bad News and Leaving Unsafe Situa-
tions. The specific role-playing exercises within these
themes are based on input from dual diagnosis patients and
mental health professionals working with these patients.
The module Streetwise involves a street skills training.
It has been suggested that teaching patients about
changeable factors that contribute to their risk of
victimization may be effective in reducing victimization
[37, 53–55]. Streetwise builds on the suggested strategies
that make patients reflect on the safety of their environ-
ment and their own contribution to safety. An important
aspect of Streetwise is safety regarding drug related be-
haviour and contact with drug dealers. All knowledge
and skills are transferred in a playful, stimulating man-
ner, using role-play and creative exercises.
CAU: Care as usual
Most participants will suffer from chronic mental health
problems. Hence, CAU is an ongoing treatment process.
CAU usually consists of pharmacotherapy in combin-
ation with a form of case management, for instance as-
sertive community treatment [56]. In addition, since
SOS training will be imbedded in addiction-psychiatry
treatment programs, when enrolling in this study most
participants will attend some form of psychosocial ther-
apy. Depending on the participants’ motivation, capacities
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and needs this may include: cognitive behavioural therapy
[57], motivational interviewing [58], substance abuse man-
agement training [59], social skills training, psychomotor
therapy and mindfulness. The type and amount of care re-
ceived by participants will be recorded.
Therapists
SOS training will be implemented in the treatment pro-
grams of an addiction-psychiatry dual diagnosis clinic
and an addiction-psychiatry outpatient care facility of
Arkin Mental Health Care, division Mentrum. Arkin is
an Amsterdam-based public mental health care treat-
ment facility. Eight employees are selected to be trained
to deliver the intervention. These SOS-trainers work in
various positions, for instance as psychologist, nurse or
social worker. All have ample experience in working
with psychiatric patients with substance use disorders
and are motivated to implement this new intervention.
The SOS-trainers will follow a detailed training manual
which describes each training session. Each session will be
led by an SOS-trainer accompanied by an SOS-co-trainer.
Therapist education
The education for SOS-trainers includes: studying the
SOS training manual independently and two 3-h group
training sessions, which will be provided by one of the
researchers. The first group training session consists of:
the theoretical framework of SOS training, an explan-
ation of the exercises in module Streetwise and practis-
ing these exercises. The second group training session
consists of: an explanation of the exercises in module
Self-wise and Other-wise and practising these exercises.
The researcher who provides the education for SOS-
trainers will be present at the delivery of the first 12 ses-
sions SOS training on both locations, to provide additional
feedback to the SOS-trainers after each session. Thereafter,
this researcher will attend an SOS training session at least
once every month on both locations. After 6 months, an
individual evaluation will be held with every SOS-trainer.
Procedure
Recruitment and consent
Patients will be recruited in an addiction-psychiatry dual
diagnosis clinic and an addiction-psychiatry outpatient
care facility. All patients who fit the inclusion criteria,
will be informed and invited by their mental health care
facility. Participants will receive a participation compen-
sation of 15 Euros per assessment for T0, T1 and T2
and 30 Euros for T3. Written informed consent will be
provided before the first assessment takes place.
Randomization and treatment allocation
Participants will be allocated to CAU + SOS training or
CAU by an independent researcher using a computer-
generated block randomization schedule. Randomization
will be stratified by two prognostic factors: treatment
centre (clinic/outpatient care) and victimization in the
year prior to baseline (yes/no). Block size varies randomly.
To prevent selection bias, the research coordinator and
outcome assessors are denied access to the randomization
schedule and are blind to block size and order.
Trial flow
Figure 1 provides an overview of the trial flow diagram.
After informed consent is provided and baseline assess-
ment (T0) has taken place, participants will be random-
ized and allocated to either CAU + SOS training or
continue to receive CAU. Follow-up assessments will
take place 2, 8 and 14 months after baseline assessment.
For participants allocated to trial arm CAU + SOS train-
ing this will correspond to immediately, 6 months and
12 months after the completion of SOS training.
Measurements
Table 1 provides an overview of the measurement in-
struments. All instruments will be administered in the
form of an interview, by a junior researcher (MSc in
Psychology) or master student (holding a BSc) in clinical
psychology. To minimize bias, the junior researcher will
train the master student in carefully collecting data and
interviewing participants. This training will start with
two days consisting of explanation and role plays. After
that, the master student will watch the junior researcher
administer assessments. Finally, the junior researcher
will supervise the first assessments administered by the
master student and give feedback.
Both outcome assessors will be blind to the trial arm to
which the participant is allocated after randomization. To
verify blinding, after each follow-up assessment the asses-
sor will record to which trial arm he/she thinks the par-
ticipant is allocated. Furthermore, the assessor will record
his/her confidence regarding these thoughts on allocation.
Primary outcome measure: victimization
Victimization will be measured with the Dutch version
of the Safety Monitor (in Dutch: Veiligheidsmonitor, VM
section 4), developed by the Dutch Ministry of Security
and Justice [60]. The Safety Monitor is an instrument
used by Statistics Netherlands (CBS) to measure
victimization on a large scale (almost 80 thousand cases
a year). It is an adequate self-report instrument that
strongly resembles the International Crime Victimization
Survey (ICVS) [61]. Section 4 of the Safety Monitor as-
sesses victimization of 11 different crimes, subdivided in
three categories:
– violent crimes, consisting of: sexual crimes, threats
and assaults;
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– property crimes, consisting of: burglary, theft from
car, car theft, motor vehicle theft, bicycle theft,
robbery and theft of other property;
– vandalism;
The Safety Monitor examines whether participants ex-
perienced each specific crime in the last 5 years. If so,
they are asked whether they experienced that crime in
the last 12 months. For each crime reported, participants
are asked how frequently they experienced that crime in
the last 12 months.
The primary outcome measure is treatment response
(yes/no), defined as either no victimization at T3 or at
least a 50 % reduction in incidents of victimization at T3
compared to T0. Since there are no previous random-
ized controlled trials available that aimed to reduce
victimization in this target group, our treatment re-
sponse criteria are based on experts opinions. Mental
health care professionals working with dual diagnosis
patients indicated a 50 % reduction in incidents of
victimization as a clinically relevant and achievable goal.
Key secondary outcome measures
Violent victimization and property victimization
The Safety Monitor subcategories violent victimization
and property victimization will be examined separately.
Substance use (disorders)
Substance use in the past 90 days will be measured with
the Timeline Followback (TLFB) [62], which has good
reported reliability and validity in dual diagnosis popula-
tions [63, 64]. Using calendars, beginning on the day of
assessment and working backwards, participants recon-
struct daily substance use.
The Alcohol Use Disorder Identification Test (AUDIT)
[65], developed by the World Health Organization
(WHO) will be included to measure alcohol consump-
tion burden. The AUDIT has shown good reliability and
Fig. 1 Flow chart of the study design
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validity in various target groups [66] including individ-
uals with severe mental illness [66–68]. The Drug Use
Disorder Identification Test (DUDIT) [69], developed as
a parallel instrument to the AUDIT, will be included to
measure drug consumption burden. The DUDIT has
shown good reliability and validity in individuals with
psychosis [70] and in substance abusers in various treat-
ment settings [69, 71].
Psychopathology
Psychopathology will be measured with the Brief Psychi-
atric Rating Scale-Expanded (BPRS-E) [72, 73], which
evaluates a broad range of psychiatric symptoms. The
BPRS-E is often used as measure of symptom outcome in
psychiatric populations [74]. The clinician-administered
instrument is sensitive to change in symptom severity, is
valid [74, 75] and reliable [74, 76], also in patients with
dual diagnosis [77].
Emotion dysregulation
Emotion dysregulation will be measured with the Diffi-
culties in Emotion Regulation Scale (DERS) [78]. The
DERS evaluates clinically relevant emotion regulation
difficulties across multiple domains, represented in six
subscales: non-acceptance of emotional responses, diffi-
culty engaging in goal-directed behaviour, impulse con-
trol difficulties, lack of emotional awareness, limited
access to emotion regulation strategies and lack of emo-
tional clarity. The DERS is used extensively as outcome
variable in clinical research and has high internal
consistency and good test-retest reliability and construct
validity [78, 79], also in patients with SMI [80].
Other secondary outcome measures
Other secondary outcome measures are:
– interpersonal functioning as measured with the
Inventory of Interpersonal Problems (IIP-32) [81],
– self-esteem as measured with the Self Esteem Rating
Scale (SERS-SF 20) [82],
– anger disposition as measured with the Dimensions
of Anger Reactions (DAR) [83],
– psychological distress as measured with the Kessler
psychological distress scale (K10) [84, 85],
– quality of life as measured with the EuroQol 5D
(EQ-5D-5 L) [86] and the Manchester Short
Assessment of Quality of Life (MANSA) [87],
– healthcare costs and productivity losses/gains as
measured with the Trimbos/iMTA questionnaire on
Costs associated with Psychiatric illness (TiC-P) [88].
Other variables of interest
General patient characteristics
General demographic characteristics such as age, gender,
marital status and educational level will be collected at
baseline. Furthermore, current DSM-IV diagnosis, total
days of hospitalisation, all-cause mortality, Global As-
sessment of Functioning (GAF) and mental healthcare
Table 1 Overview of measurement instruments
Measurement instrument T0 T1 T2 T3a
Safety Monitor x x
Questions regarding likelihood and controllability of victimization x x x x
Timeline Followback x x x x
Alcohol Use Disorder Identification Test x x x
Drug Use Disorder Identification Test x x x
Brief Psychiatric Rating Scale x x x x
Kessler psychological distress scale x x x x
Difficulties in Emotion Regulation Scale x x x x
Dimensions of Anger Reactions x x x x
Inventory of Interpersonal Problems x x x x
Self Esteem Rating Scale x x x x
EuroQol 5D x x x x
Manchester Short Assessment of Quality of Life x x x x
Trimbos questionnaire on Costs associated with Psychiatric illness x x x
Jellinek PTSD Screening Questionnaire x x
Posttraumatic Diagnostic Scale x x
Mini-Mental State Examination x
Client Satisfaction Questionnaire x x x
aT0 baseline, T1 2 months follow-up, T2 8 months follow-up, T3 14 months follow-up
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received by participants will be extracted from the elec-
tronic patient record.
Context of victimization
For all crimes reported, context information on
victimization will be examined with the Safety Monitor.
Each crime reported will be followed by an exploration
of the most recent incident. The Safety Monitor contains
questions on when and where the incident happened,
who the perpetrator was and whether the police was in-
formed. For perpetrator we added the answer options
‘friend’, ‘drug dealer’, ‘other patient’ and 'health care
worker’ in addition to the existing options.
In addition to the crimes described in the section ‘pri-
mary outcome measure’, four new types of crime that were
added in the most recent version of the Safety Monitor
will be examined. These new types of crime are: identity
fraud, sales fraud, hacking and cyberbullying.
To obtain more detailed information on victimization
we extended the Safety Monitor with extra questions.
For sexual crimes, threats, assaults and robbery we
examine what led to the incident, whether the patient
used any substances at the time of the incident and, if
relevant, why the participant did not inform the police.
Likelihood and controllability of victimization
For each crime assessed with the Safety Monitor, ques-
tions are added that examine the perceived likelihood
and controllability of becoming a victim of this crime.
These questions are based on a risk perception study by
Jackson [89]. Participants are asked: ‘to what extent do
you feel able to control whether or not you become a
victim of the following?’ and ‘how likely do you think it
is that you will fall victim of each of the following during
the next twelve months?’. To obtain conceptual equiva-
lence, three of the researchers independently translated
the questions to Dutch and then formed a panel to re-
solve discrepancies in these forward translations. Subse-
quently, an independent translator translated the
questions back to English. We discussed discrepancies
with this translator until we reached consensus. Finally,
we successfully pre-tested the questions on 10 patients
from our study population.
Perpetration
Perpetration will be measured with the extended version
of the Safety Monitor. For each crime, participants are
asked if they have committed that crime in the last
5 years. If so, participants are asked if and how often
they permitted that crime in the last 12 months. Prior to
the assessment of perpetration, participants will be
reminded of the confidentiality of the assessment.
Within-day relationship victimization and substance use
The within-day relationship between victimization and
substance use will be examined with the TLFB [62].
First, substance use will be administered with the TLFB,
using calendars, as described in the section ‘secondary
outcome measures’. Thereafter participants will recon-
struct victimization in the past 90 days, following the
same procedure, beginning on the day of assessment and
working backwards. For each day on which both
victimization and substance use are reported, the within-
day process will be examined. Participants will be asked
to indicate whether they used substances before being
victimized, after being victimized, or both. The TLFB
has previously been used to assess partner violence and
victimization and their within-day relation to substance
use [90–93].
Post-traumatic stress disorder
The Jellinek PTSD Screening Questionnaire [94] will be
included to screen for post-traumatic stress disorder
symptoms. If a participant tests positive, post-traumatic
stress disorder symptoms are measured using the Post-
traumatic Diagnostic Scale (PDS) [95].
Cognitive impairment
The Mini-Mental State Examination (MMSE) will be in-
cluded to screen for cognitive impairment.
Client satisfaction with treatment services
The Client Satisfaction Questionnaire (CSQ-8) [96, 97]
will be included to measure participants’ satisfaction
with their mental health treatment services.
Observation scales
For each participant in the clinic, two observation scales
will be independently administered by two out of eight
nurses, who are not otherwise involved in the SOS train-
ing or research. Social functioning will be measured with
the Personal and Social Performance scale (PSP) [98].
Aggressive and social behaviour will be measured with
the Observation Scale for Aggressive Behaviour (OSAB)
[99], which consists of the subscales: irritation/anger,
anxiety/gloominess, aggressive behaviour, antecedent (to
aggressive behaviour), sanction (for aggressive behav-
iour) and social behaviour. Due to practical reasons, the
observation scales will only be administered for hospital-
ized participants.
Evaluation of treatment
After each training session, the SOS-trainers will fill in a
session evaluation form in which they note to what ex-
tent they followed the instructions in the SOS training
manual (scale 1–10) and which participants were
present, including a mark (scale 1–10) for effort.
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After completing each module of SOS training, partici-
pants randomized to CAU + SOS training will fill in a
questionnaire to evaluate that module. Each evaluation
contains the questions: ‘how much fun was this module
to you?’ and ‘how helpful was this module to you?’ (both
scale 0–10). Subsequently, participants rate three
module-specific skills on a scale from 0 to 100, with 0
being ‘I did not improve on this at all’ and 100 being ‘I
improved on this a lot’. Finally, participants will rate
how much they improved on self-confidence and on
controllability of becoming a victim of crime, due to fol-
lowing this module (scale from 0 to 100).
Data analysis
Sample size calculation
A priori sample size calculations were performed using
G*power 3.1.9.2. We are the first to explore effects of an
intervention to reduce victimization in this target group,
which makes it impossible to provide an exact estimate
of effect size for the main outcome measure in this sam-
ple. In order to be able to detect a 20 % difference in
treatment response between the two trial arms (50 %
treatment response in SOS training + CAU versus 30 %
treatment response in CAU) with α = .05 and power = .80,
the total sample size should be at least 186 (N CAU+ SOS
training = 93, N CAU= 93). Since a drop-out of 25 % can
be expected in this target group we aim to include 250
participants.
Effectiveness
Primary data analyses will be performed in accordance
with the intention-to-treat paradigm. In addition, per
protocol analyses will be conducted. Missing data will be
addressed using multiple imputation. Statistical signifi-
cance will be set at α < .05, based on two-sided tests.
The effect of treatment in terms of the primary and sec-
ondary outcome variables will be analysed with general-
ized linear mixed model regression analysis (GLMM)
with adequate link functions, taking into account distri-
butional characteristics of the data.
Costs
We will consider four types of costs: (1) the costs of of-
fering the intervention (SOS training + CAU or CAU),
(2) costs stemming from general health care uptake be-
sides SOS training + CAU or CAU, including the costs
of medication, (3) patients' out-of-pocket expenses (eg
traveling costs, leisure time spent on receiving care), (4)
costs stemming from productivity losses due to absen-
teeism or reduced efficiency while at work (presentee-
ism). The first two types of costs are also known as the
direct medical costs and these will be based on the full
economic costs of offering the interventions. Here, we
will use the pertinent Dutch guideline for economic
evaluation [100], and rely on the standard cost prices re-
ported therein. Productivity losses will be based on the
gender- and age-specific labour costs. Data on resource
use (health care uptake) and productivity losses will be
collected with the widely used TiC-P [88].
Effects
As effect measure, the 5-level variant of the 5-dimensional
EuroQol instrument (EQ-5D-5 L) [86] will be used to
compute health gains expressed in quality adjusted life
years (QALYs). Health utilities are a major feature of the
EQ-5D instrument. As the EQ-5D-5 L is relatively recent
update of the 3-level EQ-5D, studies that directly elicit
preferences from general population samples to derive
value sets to calculate the EQ-5D-5 L health utilities are
under development in a number of countries, including
the Netherlands [101]. In the interim, the EuroQol Group
coordinated a study that administered both the 3-level
and 5-level versions of the EQ-5D, in order to develop a
“crosswalk” between the EQ-5D-3 L value sets and the
new EQ-5D-5 L descriptive system, resulting in crosswalk
value sets for the EQ-5D-5 L [102]. It is expected that the
new utilities for the EQ-5D-5 L will be available when we
will perform the calculations for the economic evaluation;
otherwise we will use the crosswalk from the EuroQol
Group to calculate health utilities.
Cost-effectiveness calculations
The economic evaluation will be conducted alongside
the randomized trial, taking into account the CHEERS
statement [103] and the 2015 ISPOR good research
practices task force report on cost-effectiveness analysis
alongside clinical trials [104]. Technically, the economic
evaluation referred to as cost-effectiveness analysis in
the following section will be a cost-utility analysis as
health utilities are used as the effect measure.
Using the area under the curve (AUC) method, the pe-
riods between the measurement waves will be weighted
by the utility of the health state in that period. This al-
lows the computation of quality adjusted life years
(QALYs) over the entire trial period. In similar vein, cu-
mulative costs over the entire follow-up period will be
obtained from the cost estimates at the various measure-
ment waves. The cost-utility evaluation will be per-
formed in line with suggestions by Drummond et al.
(2005) [105], i.e. in agreement with the intention-to-treat
principle, with missing data addressed using imputation.
The incremental cost-effectiveness ratio (ICER) will be
calculated as follows: ICER = (C1-C2)/(E1-E2), where C
stands for costs, E for effects, and subscripts 1 and 2 refer
to the two trial arms (SOS training + CAU and CAU,
respectively). Confidence intervals around the ICER will
be calculated using a non-parametric bootstrap approach:
5,000 non-parametric bootstrapped samples will be
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extracted from the original dataset. For each of these boot-
strapped samples, the incremental costs, incremental ef-
fects, and the incremental cost-effectiveness ratio (ICER)
will be calculated. The resulting 5,000 ICERs will be used
for further calculations and will be plotted on a cost-
effectiveness plane. In addition, cost-effectiveness accept-
ability curves (CEACs) will be constructed. One-way
sensitivity analyses directed at uncertainty in the main
cost drivers will be performed to gauge the robustness of
our findings. In addition, a sensitivity analysis in which a
covariate-adjusted CEAC curve is constructed will be con-
ducted using net benefit regression methods [106, 107].
Ethical approval
This RCT has been reviewed and approved by the ethics
committee of the Academic Medical Center of the Univer-
sity of Amsterdam, Amsterdam, The Netherlands and will
be conducted in accordance with the Declaration of
Helsinki [108].
Discussion
Patients with comorbid mental and substance use disor-
ders are vulnerable to victimization [1–5]. There is a
strong need for interventions that reduce victimization
of patients [2–4, 37, 53]. This randomized clinical trial is
the first to test the effectiveness of an intervention that
aims to reduce vulnerability for victimization in patients
with dual diagnosis. We will test whether adding the
Self-wise, Other-wise, Streetwise (SOS) training to care
as usual results in a reduction of victimization. Besides,
we will examine improvement on secondary outcome
measures and cost-effectiveness.
Previous studies testing the effectiveness of psychosocial
interventions in similar target groups have been hampered
by small samples, poor experimental design, short follow-
up periods and high loss to treatment and loss to follow-
up [40]. Major strengths of this study are the follow-up
period of 14 months, the relatively large sample size of
250 individuals and the large battery of validated and clin-
ically relevant outcome measures. Furthermore, those
assessing outcomes will be blind to treatment allocation.
Our main challenges in this study are expected to be treat-
ment adherence and preventing drop-out. We will work
closely together with patients’ mental health care profes-
sionals to prevent drop-out as much as possible. More-
over, participants will receive monetary compensation for
completing follow-up assessments. Finally, missing data
will be addressed using multiple imputation.
If SOS training is effective in reducing vulnerability for
victimization it can be implemented in mental health care
and contribute to the safety and well-being of patients.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MdW drafted the manuscript, which was modified by AG, MK, MB and JD.
MB drafted the sections on costs, effects and cost-effectiveness calculations.
All authors participated in the design of the study. All authors read and
approved the final manuscript.
Acknowledgments
This research is part of the Violence Against Psychiatric Patients programme,
financed by the Netherlands Organisation for Scientific Research (NWO)
(grant number 432-12-804 awarded to JD, AEG, MB and MK). We thank Judith
Bosmans (Vrije Universiteit, Amsterdam) who contributed to constructing an
appropriate version of the Trimbos/iMTA questionnaire on Costs associated
with Psychiatric illness (TiC-P).
Author details
1Department of Research, Arkin Mental Health Care, Klaprozenweg 111, 1033
NN, Amsterdam, The Netherlands. 2Academic Medical Center, Department of
Psychiatry, Amsterdam Institute for Addiction Research, University of
Amsterdam, Amsterdam, The Netherlands. 3Trimbos Institute – Netherlands
Institute of Mental Health and Addiction, Da Costakade 45, 3521 VS Utrecht,
The Netherlands. 4Department of Clinical Psychology, Vrije Universiteit
Amsterdam, Amsterdam, The Netherlands.
Received: 22 July 2015 Accepted: 16 October 2015
References
1. Choe JY, Teplin LA, Abram KM. Perpetration of violence, violent
victimization, and severe mental illness: balancing public health concerns.
Psychiatr Serv. 2008;59:153–64.
2. Latalova K, Kamaradova D, Prasko J. Violent victimization of adult patients
with severe mental illness: a systematic review. Neuropsychiatr Dis Treat.
2014;10:1925–39.
3. Maniglio R. Severe mental illness and criminal victimization: a systematic
review. Acta Psychiatr Scand. 2009;119:180–91.
4. Kamperman AM, Henrichs J, Bogaerts S, Lesaffre EM, Wierdsma AI,
Ghauharali RR, et al. Criminal victimisation in people with severe mental
illness: a multi-site prevalence and incidence survey in the Netherlands.
PLoS One. 2014;9:e91029.
5. Sells DJ, Rowe M, Fisk D, Davidson L. Violent victimization of persons with
co-occurring psychiatric and substance use disorders. Psychiatr Serv.
2003;54:1253–7.
6. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry.
2004;56:730–7.
7. Resnick HS, Acierno R, Kilpatrick DG. Health impact of interpersonal violence. 2:
medical and mental health outcomes. Behav Med. 1997;23:65–78.
8. Hanson RF, Sawyer GK, Begle AM, Hubel GS. The impact of crime
victimization on quality of life. J Trauma Stress. 2010;23:189–97.
9. Robinson F, Keithley J. The impacts of crime on health and health services:
a literature review. Health, Risk & Society. 2000;2:253–66.
10. Krug EG, Mercy JA, Dahlberg LL, Zwi AB. World report on violence and
health. Biomedica. 2002;22 Suppl 2:327–36.
11. Kilpatrick DG, Acierno R. Mental health needs of crime victims:
epidemiology and outcomes. J Trauma Stress. 2003;16:119–32.
12. Messman-Moore TL, Ward RM, Zerubavel N. The role of substance use and
emotion dysregulation in predicting risk for incapacitated sexual
revictimization in women: results of a prospective investigation. Psychol
Addict Behav. 2013;27:125–32.
13. Kearns MC, Calhoun KS. Sexual revictimization and interpersonal
effectiveness. Violence Vict. 2010;25:504–17.
14. Brekke JS, Prindle C, Bae SW, Long JD. Risks for individuals with
schizophrenia who are living in the community. Psychiatr Serv.
2001;52:1358–66.
15. Walsh E, Moran P, Scott C, McKenzie K, Burns T, Creed F, et al. Prevalence of
violent victimisation in severe mental illness. Br J Psychiatry. 2003;183:233–8.
16. Newman JM, Turnbull A, Berman BA, Rodrigues S, Serper MR. Impact of
traumatic and violent victimization experiences in individuals with
schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 2010;198:708–14.
17. Goodman LA, Salyers MP, Mueser KT, Rosenberg SD, Swartz M, Essock SM,
et al. Recent victimization in women and men with severe mental illness:
prevalence and correlates. J Trauma Stress. 2001;14:615–32.
de Waal et al. BMC Psychiatry  (2015) 15:267 Page 9 of 11
18. Fisher HL, Roberts A, Day F, Reynolds N, Iacoponi E, Garety PA, et al. Impact
of crime victimization on initial presentation to an early intervention for
psychosis service and 18-month outcomes. Early Interv Psychiatry. 2015.
doi:10.1111/eip.12219.
19. Hiday VA, Swanson JW, Swartz MS, Borum R, Wagner HR. Victimization: a link
between mental illness and violence? Int J Law Psychiatry. 2001;24:559–72.
20. de Vries S, Kamperman A, Lako I, Sytema S, Bervoets P, van der Gaag M,
et al. Geweld tegen psychiatrisch patienten in Nederland. Maandblad
Geestelijke Volksgezondheid. 2011;66:8–19.
21. Stepp SD, Smith TD, Morse JQ, Hallquist MN, Pilkonis PA. Prospective
associations among borderline personality disorder symptoms, interpersonal
problems, and aggressive behaviors. J Interpers Violence. 2012;27:103–24.
22. Golder S, Logan TK. Cumulative victimization, psychological distress, and
high-risk behavior among substance-involved women. Violence Vict.
2011;26:477–95.
23. Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR. Prevalence of
physical and sexual abuse among substance abuse patients and impact on
treatment outcomes. Drug Alcohol Depend. 2005;78:57–64.
24. Lijffijt M, Hu K, Swann AC. Stress modulates illness-course of substance use
disorders: a translational review. Front Psychiatry. 2014;5:83.
25. Stevens A, Berto D, Frick U, Kerschl V, McSweeny T, Schaaf S, et al. The
victimization of dependent drug users: findings from a european study, UK.
Eur J Criminol. 2007;4(4):385–408.
26. Lam JA, Rosenheck R. The effect of victimization on clinical outcomes of
homeless persons with serious mental illness. Psychiatr Serv. 1998;49:678–83.
27. Neria Y, Bromet EJ, Carlson GA, Naz B. Assaultive trauma and illness course
in psychotic bipolar disorder: findings from the Suffolk county mental
health project. Acta Psychiatr Scand. 2005;111:380–3.
28. Teasdale B. Mental disorder and violent victimization. Criminal Justice and
Behavior. 2009;36:513–35.
29. Roodman AA, Clum GA. Revictimization rates and method variance: a
meta-analysis. Clin Psychol Rev. 2001;21:183–204.
30. Classen CC, Palesh OG, Aggarwal R. Sexual revictimization: a review of the
empirical literature. Trauma Violence Abuse. 2005;6:103–29.
31. Widom CS, Czaja SJ, Dutton MA. Childhood victimization and lifetime
revictimization. Child Abuse Negl. 2008;32:785–96.
32. Ruback RB, Clark VA, Warner C. Why are crime victims at risk of being
victimized again? Substance use, depression, and offending as mediators of
the victimization-revictimization link. J Interpers Violence. 2014;29:157–85.
33. Tseloni A, Pease K. Repeat personal victimization ‘Boosts’ or ‘Flags’? Br J
Criminol. 2003;43:196–212.
34. Wittebrood K. Slachtoffers van criminaliteit. Sociaal en Cultureel Planbureau:
Den Haag; 2006.
35. Mueser KT, Rosenberg SD, Goodman LA, Trumbetta SL. Trauma, PTSD, and
the course of severe mental illness: an interactive model. Schizophr Res.
2002;53:123–43.
36. Patel DM, Taylor RM. Social and Economic Costs of Violence: Workshop
Summary. Washington, D.C.: The National Academies Press; 2012.
37. Teplin LA, McClelland GM, Abram KM, Weiner DA. Crime victimization in
adults with severe mental illness: comparison with the national crime
victimization survey. Arch Gen Psychiatry. 2005;62:911–21.
38. Perese EF. Stigma, poverty, and victimization: roadblocks to recovery for
individuals with severe mental illness. J Am Psychiatr Nurses Assoc.
2007;13(5):285–95.
39. de Mooij LD, Kikkert M, Lommerse NM, Peen J, Meijwaard SC, Theunissen J,
et al. Victimisation in adults with severe mental disorders: prevalence and
risk factors. Br J Psychiatry. 2015.
40. Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M. Psychosocial
interventions for people with both severe mental illness and substance
misuse. Cochrane Database Syst Rev. 2013;10, CD001088.
41. Ralevski E, Olivera-Figueroa LA, Petrakis I. PTSD and comorbid AUD: a review
of pharmacological and alternative treatment options. Subst Abuse Rehabil.
2014;5:25–36.
42. Berking M, Ebert D, Cuijpers P, Hofmann SG. Emotion regulation skills
training enhances the efficacy of inpatient cognitive behavioral therapy for
major depressive disorder: a randomized controlled trial. Psychother
Psychosom. 2013;82:234–45.
43. Willner P, Rose J, Jahoda A, Kroese BS, Felce D, Cohen D, et al. Group-based
cognitive-behavioural anger management for people with mild to
moderate intellectual disabilities: cluster randomised controlled trial. Br J
Psychiatry. 2013;203:288–96.
44. Cloitre M, Stovall-McClough KC, Nooner K, Zorbas P, Cherry S, Jackson CL,
et al. Treatment for PTSD related to childhood abuse: a randomized
controlled trial. Am J Psychiatry. 2010;167:915–24.
45. van Wel EB, Bos EH, Appelo MT, Berendsen EM, Willgeroth FC, Verbraak MJ.
The efficacy of the systems training for emotional predictability and
problem solving (STEPPS) in the treatment of borderline personality
disorder. A randomized controlled trial. Tijdschr Psychiatr. 2009;51:291–301.
46. Bellack AS, Mueser KT, Gingerich S, Agresta J. Social skills training for
Schizophrenia: A step-by-step guide. 2nd Edition. New York, NY: The
Guilford Press; 2004.
47. de Waal MM, Goudriaan AE, Kikkert MJ, Dekker JJM. Handleiding SOS
Training [Manual SOS Training]. 2014.
48. Thompson RA. Emotion regulation: a theme in search of definition. Monogr
Soc Res Child Dev. 1994;59:25–52.
49. Marx BP, Heidt JM, Gold SD. Perceived uncontrollability and unpredictability,
self-regulation and sexual revictimization. Rev Gen Psychol. 2005;9:67–90.
50. Rieffe C, Camodeca M, Pouw L, Lange A, Stockman L. Don’t anger me!
Bullying, victimization, and emotion dysregulation in young adolescents
with ASD. Eur J Dev Psychol. 2012;9:351–70.
51. Stevens NR, Gerhart J, Goldsmith RE, Heath NM, Chesney SA, Hobfoll SE.
Emotion regulation difficulties, low social support, and interpersonal
violence mediate the link between childhood abuse and posttraumatic
stress symptoms. Behav Ther. 2013;44:152–61.
52. Walsh K, DiLillo D, Messman-Moore TL. Lifetime sexual victimization and
poor risk perception: does emotion dysregulation account for the links? J
Interpers Violence. 2012;27:3054–71.
53. Perese EF. Victimization of society’s. Most vulnerable citizens. J Psychosoc
Nurs Ment Health Serv. 2007;45:8–9.
54. Corrigan PW, Holmes EP. Patient identification of street skills for a
psychosocial training module. Hosp Community Psychiatry. 1994;45:273–6.
55. Holmes EP, Corrigan PW, Stephenson J, Nugent-Hirschbeck J. Learning
street smarts for an urban setting. Psychiatr Rehab J. 1997;20:64–6.
56. Stein LI, Santos AB. Assertive Community Treatment of Persons With Severe
Mental Illness. New York, NY: W. W. Norton and Co., Inc; 1998.
57. Beck JS. Cognitive Behavior Therapy. New York, NY: The Guilford Press; 2011.
58. Miller WR, Rollnick S. Motivational Interviewing. 3rd ed. New York, NY:
Guilford Press; 2012.
59. Roberts LJ, Shaner A, Eckman TA. Trainingsmodule Omgaan met verslaving
[Training module substance abuse management]. Garant: Leuven-
Apeldoorn; 2001.
60. Akkermans M, Coumans M, Kloosterman R, Linden G, Moons E.
Veiligheidsmonitor 2013. Den Haag: Centraal Bureau voor de Statistiek; 2014.
61. Killias M. International Crime Victimization Survey (ICVS). In: Encyclopedia of
Victimology and Crime Prevention. Thousand Oaks: SAGE Publications; 2010.
p. 486–9.
62. Sobell LC, Sobell MB. Timeline Followback user’s Guide: A Calendar Method
for Assessing Alcohol and Drug use. Addiction Research Foundation:
Toronto, Ontario, Canada; 1996.
63. Carey KB, Carey MP, Maisto SA, Henson JM. Temporal stability of the
timeline followback interview for alcohol and drug use with psychiatric
outpatients. J Stud Alcohol. 2004;65:774–81.
64. Stasiewicz PR, Vincent PC, Bradizza CM, Connors GJ, Maisto SA, Mercer ND.
Factors affecting agreement between severely mentally ill alcohol abusers‘
and collaterals’ reports of alcohol and other substance abuse. Psychol
Addict Behav. 2008;22:78–87.
65. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development
of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative
project on early detection of persons with harmful alcohol consumption–II.
Addiction. 1993;88:791–804.
66. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use
Disorders Identification Test: guidelines for use in primary care. 2001.
67. Dawe S, Seinen A, Kavanagh D. An examination of the utility of the AUDIT
in people with schizophrenia. J Stud Alcohol. 2000;61:744–50.
68. Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the
AUDIT and the DAST-10 to identify alcohol and drug use disorders
among adults with a severe and persistent mental illness. Psychol
Assess. 2000;12:186–92.
69. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the
Drug Use Disorders Identification Test (DUDIT) in criminal justice and
detoxification settings and in a Swedish population sample. Eur Addict
Res. 2005;11:22–31.
de Waal et al. BMC Psychiatry  (2015) 15:267 Page 10 of 11
70. Nesvag R, Lange EH, Faerden A, Barrett EA, Emilsson B, Ringen PA, et al. The
use of screening instruments for detecting alcohol and other drug use
disorders in first-episode psychosis. Psychiatry Res. 2010;177:228–34.
71. Voluse AC, Gioia CJ, Sobell LC, Dum M, Sobell MB, Simco ER. Psychometric
properties of the Drug Use Disorders Identification Test (DUDIT) with
substance abusers in outpatient and residential treatment. Addict Behav.
2012;37:36–41.
72. Lukoff D, Nuechterlein KH, Ventura J. Manual for the expanded BPRS.
Schizophr Bull. 1986;12:594–602.
73. Ruggeri M, Koeter M, Schene A, Bonetto C, Vazquez-Barquero JL, Becker T,
et al. Factor solution of the BPRS-expanded version in schizophrenic
outpatients living in five European countries. Schizophr Res. 2005;75:107–17.
74. Burlingame GM, Dunn TW, Chen S, Lehman A, Axman R, Earnshaw D, et al.
Selection of outcome assessment instruments for inpatients with severe
and persistent mental illness. Psychiatr Serv. 2005;56:444–51.
75. Kopelowicz A, Ventura J, Liberman RP, Mintz J. Consistency of brief
psychiatric rating scale factor structure across a broad spectrum of
schizophrenia patients. Psychopathology. 2008;41:77–84.
76. Schutzwohl M, Jarosz-Nowak J, Briscoe J, Szajowski K, Kallert T. Inter-rater
reliability of the brief psychiatric rating scale and the Groningen social
disabilities schedule in a european multi-site randomized controlled trial on
the effectiveness of acute psychiatric day hospitals. Int J Methods Psychiatr
Res. 2003;12:197–207.
77. Lykke J, Hesse M, Austin SF, Oestrich I. Validity of the BPRS, the BDI and the
BAI in dual diagnosis patients. Addict Behav. 2008;33:292–300.
78. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and
dysregulation: development, factor structure, and initial validation of the
difficulties in emotion regulation scale. J Psychopathol Behav Assess.
2004;26:41–54.
79. Neumann A, van Lier PA, Gratz KL, Koot HM. Multidimensional assessment
of emotion regulation difficulties in adolescents using the difficulties in
emotion regulation scale. Assessment. 2010;17:138–49.
80. Fowler JC, Charak R, Elhai JD, Allen JG, Frueh BC, Oldham JM. Construct
validity and factor structure of the difficulties in emotion regulation scale
among adults with severe mental illness. J Psychiatr Res. 2014;58:175–80.
81. Horowitz LM, Alden LE, Wiggins JS, Pincus AL. Inventory of Interpersonal
Problems. London: Psychological Corporation; 2000.
82. Lecomte T, Corbiere M, Laisne F. Investigating self-esteem in individuals
with schizophrenia: relevance of the Self-Esteem Rating Scale-Short Form.
Psychiatry Res. 2006;143:99–108.
83. Nederlof AF, Hovens JE, Muris P, Novaco RW. Psychometric evaluation of a
Dutch version of the dimensions of anger reactions. Psychol Rep.
2009;105:585–92.
84. Kessler R, Mroczek D. Final Versions of our Non-Specific Psychological
Distress Scale. Ann Arbor (MI): Survey Research Center of the Institute for
Social Research, University of Michigan; 1994.
85. Donker T, Comijs H, Cuijpers P, Terluin B, Nolen W, Zitman F, et al. The
validity of the Dutch K10 and extended K10 screening scales for depressive
and anxiety disorders. Psychiatry Res. 2010;176:45–50.
86. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al.
Development and preliminary testing of the new five-level version of EQ-5D
(EQ-5D-5 L). Qual Life Res. 2011;20:1727–36.
87. Priebe S, Huxley P, Knight S, Evans S. Application and results of the
Manchester Short Assessment of Quality of Life (MANSA). Int J Soc
Psychiatry. 1999;45:7–12.
88. Bouwmans C, De JK, Timman R, Zijlstra-Vlasveld M, Feltz-Cornelis C, Tan SS,
et al. Feasibility, reliability and validity of a questionnaire on healthcare
consumption and productivity loss in patients with a psychiatric disorder
(TiC-P). BMC Health Serv Res. 2013;13:217.
89. Jackson J. Revisiting risk sensitivity in the fear of crime. J Res Crime Delinq.
2011;000:1–25.
90. Parks KA, Fals-Stewart W. The temporal relationship between college
women’s alcohol consumption and victimization experiences. Alcohol Clin
Exp Res. 2004;28:625–9.
91. Epstein-Ngo QM, Cunningham RM, Whiteside LK, Chermack ST, Booth BM,
Zimmerman MA, et al. A daily calendar analysis of substance use and dating
violence among high risk urban youth. Drug Alcohol Depend.
2013;130:194–200.
92. Rothman EF, Stuart GL, Winter M, Wang N, Bowen DJ, Bernstein J, et al.
Youth alcohol use and dating abuse victimization and perpetration: a test
of the relationships at the daily level in a sample of pediatric emergency
department patients who use alcohol. J Interpers Violence. 2012;27:2959–79.
93. Stuart GL, Moore TM, Elkins SR, O’Farrell TJ, Temple JR, Ramsey SE, et al. The
temporal association between substance use and intimate partner violence
among women arrested for domestic violence. J Consult Clin Psychol.
2013;81:681–90.
94. Van DD, Ehring T, Vedel E, Emmelkamp PM. Screening for posttraumatic
stress disorder in civilian substance use disorder patients: cross-validation of
the Jellinek-PTSD screening questionnaire. J Subst Abuse Treat. 2013;44:126–31.
95. Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure
of posttraumatic stress disorder: the posttraumatic diagnostic scale. Psychol
Assess. 1997;9:445–51.
96. Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric
properties and correlations with service utilization and psychotherapy
outcome. Eval Program Plann. 1982;5:233–7.
97. De Wilde EF, Hendriks VM. The client satisfaction questionnaire: psychometric
properties in a Dutch addict population. Eur Addict Res. 2005;11:157–62.
98. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development,
reliability and acceptability of a new version of the DSM-IV Social and
Occupational Functioning Assessment Scale (SOFAS) to assess routine social
functioning. Acta Psychiatr Scand. 2000;101:323–9.
99. Hornsveld RH, Nijman HL, Hollin CR, Kraaimaat FW. Development of the
Observation Scale for Aggressive Behavior (OSAB) for Dutch forensic
psychiatric inpatients with an antisocial personality disorder. Int J Law
Psychiatry. 2007;30:480–91.
100. Hakkaart-van RL, Tan S, Bouwmans C. Handleiding voor kostenonderzoek,
methoden en standaard kostprijzen voor economische evaluaties in de
gezondheidszorg [Manual for Cost Research, Methods and Standard Cost
Prices for Economic Evaluations in Health Care]. Diemen: College voor
Zorgverzekeringen; 2010.
101. EuroQol Group. EQ-5D-5L Value Sets. Rotterdam: EuroQol Research
Foundation; 2015.
102. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D,
et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L
value sets. Value Health. 2012;15:708–15.
103. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D,
et al. Consolidated Health Economic Evaluation Reporting Standards
(CHEERS) statement. BMJ. 2013;346:f1049.
104. Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al.
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good
Research Practices Task Force report. Value Health. 2015;18:161–72.
105. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for
the Economic Evaluation of Health Care Programmes. Oxford: Oxford
University Press; 2005.
106. Hoch JS, Rockx MA, Krahn AD. Using the net benefit regression framework
to construct cost-effectiveness acceptability curves: an example using data
from a trial of external loop recorders versus Holter monitoring for ambulatory
monitoring of “community acquired” syncope. BMC Health Serv Res. 2006;6:68.
107. Isaranuwatchai W, Markle-Reid M, Hoch JS. Adjusting for baseline covariates
in Net benefit regression: How You adjust matters. Pharmacoeconomics.
2015;33(10):1083–90.
108. General Assembly of the World Medical Association. World Medical
Association Declaration of Helsinki: ethical principles for medical research
involving human subjects. J Am Coll Dent. 2014;81:14–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
de Waal et al. BMC Psychiatry  (2015) 15:267 Page 11 of 11
